Home › Funds › BONNESS ENTERPRISES INC › GSK

BONNESS ENTERPRISES INC position in GSK

GSK PLC ADR F · Health Care

BONNESS ENTERPRISES INC reported holding 41,480 shares of GSK (GSK PLC ADR F) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.65% of its reported portfolio and ranking #32 among its reported holdings. BONNESS ENTERPRISES INC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)41.48K sh
Reported value held$2.00M
Portfolio Weight0.65%
First reportedQ3 2023
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How BONNESS ENTERPRISES INC's GSK position evolved

BONNESS ENTERPRISES INC first disclosed a stake in GSK in Q3 2023 at 52,960 shares (US$1.9M). The position peaked in Q1 2026 at 41,480 shares, worth US$2.3M. Across 13 filings, BONNESS ENTERPRISES INC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 41,480 shares valued at US$2.0M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 52.96K $1.92M New
Q4 2023 52.96K $1.96M Hold
Q1 2024 52.96K $2.27M Hold
Q2 2024 52.96K $2.04M Hold
Q3 2024 52.96K $2.17M Hold
Q4 2024 41.48K $1.40M Reduce
Q1 2025 41.48K $1.61M Hold
Q2 2025 41.48K $1.59M Hold
Q3 2025 41.48K $1.79M Hold
Q4 2025 41.48K $2.03M Hold
Q1 2026 41.48K $2.29M Hold
Q2 2026 41.48K $2.17M Hold
Q3 2026 41.48K $2.00M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has BONNESS ENTERPRISES INC held GSK?

BONNESS ENTERPRISES INC has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BONNESS ENTERPRISES INC's current position in GSK?

As of Q3 2026, BONNESS ENTERPRISES INC holds 41.48K shares of GSK (GSK PLC ADR F), valued at $2.00M, representing 0.65% of its reported portfolio and ranking #32.

Has BONNESS ENTERPRISES INC been buying or selling GSK?

In the latest 13F filing (Q3 2026), BONNESS ENTERPRISES INC held unchanged its position in GSK. The position peaked in Q1 2026 at 41.48K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.